SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $8,934,000 | -45.3% | 335,000 | -36.8% | 13.38% | -13.5% |
Q2 2021 | $16,319,000 | +16.7% | 530,000 | -0.7% | 15.46% | +38.9% |
Q1 2021 | $13,980,000 | +19.5% | 534,000 | +14.8% | 11.13% | +43.7% |
Q4 2020 | $11,699,000 | -13.9% | 465,000 | -13.6% | 7.75% | -38.1% |
Q4 2016 | $13,591,000 | +44.8% | 538,241 | +41.8% | 12.52% | +79.3% |
Q3 2016 | $9,386,000 | -29.9% | 379,533 | -42.3% | 6.98% | +13.7% |
Q2 2016 | $13,394,000 | -2.8% | 657,533 | -27.2% | 6.14% | -4.8% |
Q1 2016 | $13,779,000 | -2.5% | 903,533 | -14.1% | 6.45% | -3.0% |
Q4 2015 | $14,129,000 | +28.7% | 1,051,277 | +34.3% | 6.65% | +2.4% |
Q3 2015 | $10,982,000 | – | 782,746 | – | 6.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |